Microfluidic device can extract CTCs from blood samples

04/26/2012 | CNET

Researchers from Harvard University and Children's Hospital Boston have developed a device for extracting circulating tumor cells from blood. Tests on mice with breast cancer showed the microfluidic device can catch more than 90% of the cancerous cells and keep them intact for culturing, according to findings published in the journal Lab on a Chip. The device has other potential uses, such as in gathering stem cells from blood.

View Full Article in:

CNET

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC